ZEVRA THERAPEUTICS, INC.
KMPH US4884452065
Annual Performance 1
2021 | 2022 | 2023 | 2024 | 2025 |
---|---|---|---|---|
4048% | -50% | 28% | 0% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
Person | Price | Shares | Total | Published | Completed |
---|---|---|---|---|---|
Shih Alvin |
7.89 USD |
20,000 Bought |
157,800 USD |
12/09/2025 | 12/09/2025 |
Favorito Tamara A |
7.79 USD |
3,175 Bought |
24,718 USD |
12/09/2025 | 12/09/2025 |
Bode John B |
9.17 USD |
5,000 Bought |
45,825 USD |
19/08/2025 | 19/08/2025 |
Thompson Rahsaan CLO |
9.21 USD |
24,000 Sold |
221,004 USD |
26/06/2025 | 26/06/2025 |
Watton Corey Michael |
7.84 USD |
300 Bought |
2,352 USD |
28/03/2025 | 28/03/2025 |
Bode John B |
7.96 USD |
10,000 Bought |
79,624 USD |
19/03/2025 | 19/03/2025 |
Mcfarlane Neil F. CEO |
8.05 USD |
30,544 Sold |
245,962 USD |
13/02/2025 | 14/02/2025 |
Mcfarlane Neil F. CEO |
7.86 USD |
61,273 Sold |
481,428 USD |
13/02/2025 | 13/02/2025 |
Clifton R. Laduane CFO |
7.86 USD |
11,000 Sold |
86,471 USD |
13/02/2025 | 13/02/2025 |
Schafer Joshua CCO |
7.86 USD |
10,500 Sold |
82,527 USD |
13/02/2025 | 13/02/2025 |